Literature DB >> 7459865

Confirmation of the two-step nature of chemical carcinogenesis in the rat colon adenocarcinoma model.

A P Maskens.   

Abstract

Carcinomas were obtained in the large intestine of BD IX rats using four different dose levels of 1,2-dimethylhydrazine. Analyses of the relationship between dose, number of cells at risk, time, and tumor yield, together with previous observations on the biological behavior of the tumors, indicated that malignant transformation necessitates two distinct and essential changes in the affected cells. The first change is caused by the carcinogen, the effect of which is additive when similar doses are being repeated. This change is transmissible within the renewing mucosa for prolonged periods. The affected cells have no second change does not require carcinogen exposure (although continued presence of the carcinogen can probably contribute to it). It randomly affects cells having undergone the first change, at a rate which is essentially constant, at least within the considered tissue.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7459865

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  Chemoprevention of colon cancer by dietary fatty acids.

Authors:  B S Reddy
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

Review 2.  Stage-specific gene expression during hepatocarcinogenesis in the rat.

Authors:  H C Pitot
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Premalignant alterations in the lipid composition and fluidity of colonic brush border membranes of rats administered 1,2 dimethylhydrazine.

Authors:  T A Brasitus; P K Dudeja; R Dahiya
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy.

Authors:  S Goldfarb; T D Pugh; H Koen; Y Z He
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.